Finance

Beta
Lists
DWTX:NASDAQ
Dogwood Therapeutics Inc
$1.69
+1.20%
(+0.020) 1D
May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DWTX...
Open
$1.67
High
$1.70
Low
$1.66
Mkt. cap
56.83M
Avg. vol.
103.16K
Volume
27.51K
52-wk high
$9.50
52-wk low
$1.28
EPS
-$7.13
Beta
1.69
Shares outstanding
33.63M
No. of employees
8
Open
$1.67
High
$1.70
Low
$1.66
Mkt. cap
56.83M
Avg. vol.
103.16K
Volume
27.51K
52-wk high
$9.50
52-wk low
$1.28
EPS
-$7.13
Beta
1.69
Shares outstanding
33.63M
No. of employees
8
News stories
From sources across the web
About Dogwood Therapeutics Inc
CEO-
Employees8
Founded2012
HeadquartersAlpharetta, Georgia, United States
SectorBiotechnology
Websitedwtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.57M
14.52M
2.34M
2.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.35M
1.29M
1.47M
2.39M
Operating expense
3.92M
15.81M
3.81M
5.06M
Total operating expenses
3.92M
15.81M
3.81M
5.06M
Operating income
-3.92M
-15.81M
-3.81M
-5.06M
Other non operating income
-
-
-
-
EBT including unusual items
-3.81M
-15.75M
-3.75M
-4.99M
EBT excluding unusual items
-3.81M
-15.75M
-3.75M
-4.99M
Income tax expense
149.00
-1.44K
31.84K
1.19K
Effective tax rate
-
0.01%
-0.85%
-0.02%
Other operating expenses
-
-
-
-
Net income
-3.81M
-15.74M
-3.78M
-4.99M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
111.38K
80.58K
52.07K
77.35K
Interest expense
-
-
-
-
Net interest expenses
111.38K
80.58K
52.07K
77.35K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.91M
-15.81M
-3.81M
-5.06M
Gain or loss from assets sale
-
-
2.73K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer